|
CN103223172A
|
|
Medicine used for preventing and treating postmenopausal osteoporosis
|
|
CN103202821A
|
|
Calcitriol soft capsules and preparation method thereof
|
|
CN103142556A
|
|
Polysaccharide sulfate sustained-release capsule and preparation method thereof
|
|
CN103202972A
|
|
Pediatric effervescent tablets
|
|
CN103142557A
|
|
Polymannuronate sulfate slow release capsule and preparation method thereof
|
|
CN103156851A
|
|
Pseudoephedrine hydrochloride slow-release particles and preparation method thereof
|
|
CN103142638A
|
|
Pharmaceutical composition for treating gastric ulcer
|
|
CN103127030A
|
|
Propylene glycol alginate sodium sulfate enteric capsule and preparation method thereof
|
|
CN103142496A
|
|
Calcitriol controlled-release granule and preparation method thereof
|
|
CN103156855A
|
|
Paracetamol and caffeine slow-release capsule and preparation method thereof
|
|
CN103142672A
|
|
Pharmaceutical composition
|
|
CN103142637A
|
|
Capsule containing colloidal bismuth pectin
|
|
CN103142535A
|
|
Alginic sodium diester enteric tablet and preparation method thereof
|
|
CN103142539A
|
|
Alginic sodium diester controlled-release tablet and preparation method thereof
|
|
CN103142471A
|
|
Calcitriol solution and preparation method thereof
|
|
CN103156849A
|
|
Compound pseudoephedrine hydrochloride enteric-coated tablet and preparation method thereof
|
|
CN103142889A
|
|
Pellet preparation for normalizing stomach and tonifying spleen
|
|
CN103202848A
|
|
Pharmaceutical composition for treating osteoporosis
|
|
CN103142534A
|
|
Calcitriol controlled-release tablet and preparation method thereof
|
|
CN103127004A
|
|
Propylene glycol alginate sodium sulfate controlled-release granule and preparation method thereof
|
